14 Hrs
Source:
أخبار 24
_1777294237270_124456903.png&w=64&q=75){kind=small}
Agreements Signed for Biopharma Localization
The Local Content and Government Procurement Authority signed three agreements to localize the manufacturing of biotech products in Saudi Arabia, including semaglutide, avapritinib, and etcheskinumab, during the Riyadh Global Biotechnology Summit. The agreements aim to boost local content and increase innovation in the pharmaceutical industry, with expectations to contribute approximately 4.4 billion riyals to the gross domestic product and create more than 800 new jobs.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)